XBIO vs SNOA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

XBIO

54.1
AI Score
VS
XBIO Wins

SNOA

46.8
AI Score

Investment Advisor Scores

XBIO

54score
Recommendation
HOLD

SNOA

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XBIO SNOA Winner
Revenue 13.58M 1.47M SNOA
Net Income -396,000 -1.39M SNOA
Net Margin -2.9% -94.5% SNOA
Operating Income 250,000 -1.47M SNOA
ROE -6.0% -22.8% SNOA
ROA -2.3% -19.9% SNOA
Total Assets 17.10M 6.97M SNOA
Current Ratio 3.48 7.43 XBIO

Relative Price Performance (Last 90 Days)

XBIO 1M: -21.0% · 3M: -49.4% SNOA 1M: +0.9% · 3M: -10.0%

Current Technical Phase

XBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.9%), weak momentum, RSI 33

RSI (14): 33.2 · Price: $1.66

SNOA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.2 · Price: $1.17

Fundamentals Snapshot

Metric XBIO SNOA
Market Cap — —
Forward P/E -4.9 -2.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.3%
Gross Margin 1.0% 0.4%
Operating Margin -0.8% 0.0%
EPS -1.15 -1.22
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, XBIO is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.